Page last updated: 2024-11-02

piretanide and Anemia, Sickle Cell

piretanide has been researched along with Anemia, Sickle Cell in 1 studies

piretanide: potent inhibitor of chloride transport; structure

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research Excerpts

ExcerptRelevanceReference
"Patients with Hb SC disease were found to have microcytic and hyperchromic red cell indices despite mild reticulocytosis."1.27The xerocytosis of Hb SC disease. ( Ballas, SK; Larner, J; Rappaport, EF; Schwartz, E; Smith, ED; Surrey, S, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballas, SK1
Larner, J1
Smith, ED1
Surrey, S1
Schwartz, E1
Rappaport, EF1

Other Studies

1 other study available for piretanide and Anemia, Sickle Cell

ArticleYear
The xerocytosis of Hb SC disease.
    Blood, 1987, Volume: 69, Issue:1

    Topics: Adenosine Triphosphatases; Anemia, Sickle Cell; Erythrocyte Deformability; Erythrocyte Membrane; Ery

1987